[
    [
        {
            "time": "2021-06-18",
            "original_text": "开源晨会0618丨回归ROE：定价变化；道通科技、金蝶国际、芯源微、国际医学",
            "features": {
                "keywords": [
                    "ROE",
                    "定价变化",
                    "道通科技",
                    "金蝶国际",
                    "芯源微",
                    "国际医学"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药生物",
                    "科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "开源晨会0618丨回归ROE：定价变化；道通科技、金蝶国际、芯源微、国际医学",
                "Correlation": 8,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-06",
            "original_text": "6月，药企这些新动作不断",
            "features": {
                "keywords": [
                    "药企",
                    "新动作",
                    "合作",
                    "收购",
                    "剥离资产"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药生物"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "6月，药企这些新动作不断",
                "Correlation": 6,
                "Sentiment": 6,
                "Importance": 6,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 4,
                "Market_Scope": 7,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-06",
            "original_text": "医药生物行业下半年投资策略：短期有扰动 长期发展趋势向好",
            "features": {
                "keywords": [
                    "医药生物",
                    "投资策略",
                    "短期扰动",
                    "长期趋势"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药生物"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "医药生物行业下半年投资策略：短期有扰动 长期发展趋势向好",
                "Correlation": 7,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 9,
                "Entity_Density": 5,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-06",
            "original_text": "泰格医药今日大宗交易成交3.80万股，成交价185.02元溢价0.0%",
            "features": {
                "keywords": [
                    "泰格医药",
                    "大宗交易",
                    "成交价",
                    "溢价"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药生物"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "泰格医药今日大宗交易成交3.80万股，成交价185.02元溢价0.0%",
                "Correlation": 9,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 6,
                "Duration": 4,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 10,
                "Headline_Structure": 6,
                "Source_Recency": 10
            }
        },
        {
            "time": "2021-06",
            "original_text": "罕见“投资狂”：泰格医药对外投资近 50 只基金，成新药投资第一孵化器",
            "features": {
                "keywords": [
                    "泰格医药",
                    "投资狂",
                    "基金",
                    "新药孵化器"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药生物"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "罕见“投资狂”：泰格医药对外投资近 50 只基金，成新药投资第一孵化器",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-06",
            "original_text": "医药生物行业周报：医疗保障法意见稿出台 严格监管保障医保资金安全",
            "features": {
                "keywords": [
                    "医药生物",
                    "医疗保障法",
                    "意见稿",
                    "严格监管",
                    "医保资金安全"
                ],
                "sentiment_score": 0.4,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药生物"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "医药生物行业周报：医疗保障法意见稿出台 严格监管保障医保资金安全",
                "Correlation": 7,
                "Sentiment": 5,
                "Importance": 9,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 6,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-06",
            "original_text": "中泰国际：方达控股给予增持评级 首予目标价7.6港元",
            "features": {
                "keywords": [
                    "中泰国际",
                    "方达控股",
                    "增持评级",
                    "目标价"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药生物"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "中泰国际：方达控股给予增持评级 首予目标价7.6港元",
                "Correlation": 8,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 7,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-06",
            "original_text": "三方搅动千亿资本局：不靠谱的股东、不知情的药明、决不罢休的监管层",
            "features": {
                "keywords": [
                    "资本局",
                    "股东",
                    "药明",
                    "监管层"
                ],
                "sentiment_score": 0.3,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药生物"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "三方搅动千亿资本局：不靠谱的股东、不知情的药明、决不罢休的监管层",
                "Correlation": 8,
                "Sentiment": 4,
                "Importance": 9,
                "Impact": 9,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 8,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        }
    ]
]